Shanghai Xuerong Bio-Technology expands credit line using real estate

Shanghai Xuerong Bio-Technology Co., Ltd. announced on December 23, 2025, that its board of directors approved an increase in its comprehensive credit facility with the Fengxian Branch of Shanghai Rural Commercial Bank. This builds upon a previous approval from September 23, 2025, which initially secured a comprehensive credit line not exceeding 40 million yuan, guaranteed by the company’s land and properties under a maximum pledge contract.

The latest decision further increases the comprehensive credit facility by 18 million yuan, bringing the total approved amount to 58 million yuan. This expansion is also secured by the same land and property assets. As of September 30, 2025, the company’s total assets were 360,144.07 yuan, total liabilities were 225,263.13 yuan, and net profit attributable to shareholders was -6,234.84 yuan for the first nine months of 2025.

This strategic move aims to meet the company's daily operational and working capital needs, ensuring business continuity without negatively impacting its primary operations or stakeholder interests. The pledge, solely for the company's own financing, falls within the board's approval authority, thus not requiring a shareholder meeting.